Novo Nordisk | NVO - DÍVIDA





DÍVIDA Alterar Data
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bausch Health Companies USD 20.85B 191M 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.11M 251K 2025-12
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.5B 3.6M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Merck USD 49.34B 7.97B 2025-12
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 47B 11.62B 2026-03
Novo Nordisk DKK 118.72B 61.75B 2025-03
Novo Nordisk DKK 118.72B 15.94B 2025-03
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.08B 38.27M 2025-12
Sanofi EUR 20.33B 1.43B 2025-12
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Zoetis USD 9.24B 1.96B 2025-12